Live Breaking News & Updates on Smitht Dupilumab|Page 1

Stay updated with breaking news from Smitht dupilumab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Regeneron, Sanofi Receive CRL for Add-On Dupilumab sBLA for Chronic Spontaneous Urticaria

The latest indication for the dual inflammatory pathway-targeting biologic expands dupilumab's clinical availability to third chronic skin disease. ....

United States , San Antonio , Smitht Dupilumab , Marcus Maurer , Drug Administration , American Academy Of Allergy , Complete Response Letter , Biologics License Application , Itch Severity Score , Urticaria Activity Score , Charite Universitatsmedizin Berlin , American Academy , Dermatology Life Quality Index , Published October , Significantly Reduces Itch , Patients With Chronic Spontaneous Urticaria , Results From , Published February , Chronic Spontaneous Urticaria Activity , Chronic Spontaneous Urticaria ,